GL1X · GenesisL1 explorer

MolNFT v1 · #164302 · protein

Crystal structure of rxralpha lbd in complex with lg 100754 and a coactivator peptide

6STI · Retinoic acid receptor rxr-alpha: “Crystal structure of rxralpha lbd in complex with lg 100754 and a coactivator peptide”. X-ray diffraction, 1 ligand (754), 2 pockets (best druggability 0.84). MolNFT v1 #164302 on GenesisL1: 3D…

PDB
6STI
Type
protein
Length
225 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 2 peptide
UniProt
P19793
Ligands
754
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21369% helix, 3% strandP19793
BNuclear receptor coactivator 2 peptideprotein1267% helix, 0% strand—

Ligands and binding sites

  • 754 · (2E,4E,6Z)-3-methyl-7-(5,5,8,8-tetramethyl-3-propoxy-5, 6,7,8-tetrahydronaphthalen-2-yl)octa-2,4,6-trienoic acid · ligand · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13160.840.9442754, ACT
21600.520.7925empty

Interfaces

1 interface between chains.

  • A–B · 591 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 6STI · Crystal structure of RXRalpha LBD in complex with LG 100754 and a coactivator peptide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.